Cargando…
Differences in isotretinoin start, interruption, and early termination across race and sex in the iPLEDGE era
BACKGROUND: iPLEDGE is the mandatory regulatory program for isotretinoin in the United States, aimed to prevent isotretinoin-related teratogenicity. However, little is known about potential unintended impact of the program, including delay in isotretinoin initiation, course interruption, and prematu...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6435230/ https://www.ncbi.nlm.nih.gov/pubmed/30913210 http://dx.doi.org/10.1371/journal.pone.0210445 |